{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:58:08Z","timestamp":1776153488923,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":106,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.schres.2012.12.023","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T00:46:31Z","timestamp":1360370791000},"page":"36-42","source":"Crossref","is-referenced-by-count":121,"title":["Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder"],"prefix":"10.1016","volume":"145","author":[{"given":"Sigrun","family":"Hope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Eiel","family":"Steen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Dieset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steinar","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiah O.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2012.12.023_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-859X-9-20","article-title":"Global Assessment of Functioning (GAF): properties and frontier of current knowledge","volume":"9","author":"Aas","year":"2010","journal-title":"Ann. Gen. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2012.12.023_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.physbeh.2009.04.024","article-title":"Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure","volume":"98","author":"Arakawa","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.schres.2012.12.023_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-9-23","article-title":"TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation","volume":"9","author":"Belarbi","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.schres.2012.12.023_bb0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4088\/JCP.v68n0614","article-title":"The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study","volume":"68","author":"Birkenaes","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2012.12.023_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4530(96)00042-X","article-title":"Central mediation of the effects of interleukin-1 on social exploration and body weight in mice","volume":"22","author":"Bluth\u00e2e","year":"1997","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.schres.2012.12.023_bb0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/eje.1.02125","article-title":"Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency","volume":"154","author":"Bollerslev","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.schres.2012.12.023_bb0035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/schbul\/sbm128","article-title":"Validity of the premorbid adjustment scale","volume":"34","author":"Brill","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbi.2008.09.007","article-title":"Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans","volume":"23","author":"Brydon","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.schres.2012.12.023_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrg2381","article-title":"Psychiatric genetics: progress amid controversy","volume":"9","author":"Burmeister","year":"2008","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.schres.2012.12.023_bb0050","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.tins.2008.07.005","article-title":"Targeting TNF-alpha receptors for neurotherapeutics","volume":"31","author":"Chadwick","year":"2008","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.schres.2012.12.023_bb0055","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2012.12.023_bb0060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","article-title":"Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study","volume":"200","author":"Chen","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11481-012-9382-z","article-title":"Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan","volume":"7","author":"Chen","year":"2012","journal-title":"J. NeuroImmune Pharm."},{"issue":"8","key":"10.1016\/j.schres.2012.12.023_bb0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1092852900020393","article-title":"Cytokine polymorphisms in the pathophysiology of mood disorders","volume":"14","author":"Clerici","year":"2009","journal-title":"CNS Spectr."},{"issue":"1","key":"10.1016\/j.schres.2012.12.023_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis","volume":"54","author":"Diez-Ruiz","year":"1995","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.schres.2012.12.023_bb0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2012.12.023_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.schres.2012.12.023_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-387718-5.00007-9","article-title":"Immune and neuroimmune alterations in mood disorders and schizophrenia","volume":"101","author":"Drexhage","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.schres.2012.12.023_bb0100","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.schres.2012.12.023_bb0105","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-5618.2010.00853.x","article-title":"Autoimmune diseases, bipolar disorder, and non-affective psychosis","volume":"12","author":"Eaton","year":"2010","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.comppsych.2008.08.010","article-title":"Remission in schizophrenia: analysis in a naturalistic setting","volume":"50","author":"Eberhard","year":"2009","journal-title":"Compr. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0115","first-page":"109","article-title":"Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment","volume":"10","author":"Erba\u00e6gci","year":"2001","journal-title":"Mediat. Inflamm."},{"issue":"2\u20133","key":"10.1016\/j.schres.2012.12.023_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.psychres.2008.11.007","article-title":"Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR)","volume":"176","author":"Freudenreich","year":"2010","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.schres.2012.12.023_bb0125","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI119488","article-title":"Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein","volume":"99","author":"Gabay","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.schres.2012.12.023_bb0130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature","volume":"70","author":"Goldstein","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"16","key":"10.1016\/j.schres.2012.12.023_bb0135","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/WNR.0b013e3282f0d3db","article-title":"Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells","volume":"18","author":"Gomez-Santos","year":"2007","journal-title":"NeuroReport"},{"key":"10.1016\/j.schres.2012.12.023_bb0140","series-title":"Manic-depressive Illness","author":"Goodwin","year":"1990"},{"issue":"4","key":"10.1016\/j.schres.2012.12.023_bb0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ps.56.4.420","article-title":"Using the GAF as a national mental health outcome measure in the Department of Veterans Affairs","volume":"56","author":"Greenberg","year":"2005","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2012.12.023_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2008.10.014","article-title":"Reproducibility of serum cytokines and growth factors","volume":"45","author":"Gu","year":"2009","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.schres.2012.12.023_bb0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2012.12.023_bb0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"11","author":"Hope","year":"2009","journal-title":"Bipolar Disord."},{"issue":"5","key":"10.1016\/j.schres.2012.12.023_bb0165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1503\/jpn.090088","article-title":"Osteoprotegerin levels in patients with severe mental disorders","volume":"35","author":"Hope","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"issue":"12","key":"10.1016\/j.schres.2012.12.023_bb0160","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","author":"Hope","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.schres.2012.12.023_bb0175","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1159\/000343302","article-title":"C-reactive protein increases bbb permeability: implications for obesity and neuroinflammation","volume":"30","author":"Hsuchou","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-5618.2009.00663.x","article-title":"Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia","volume":"11","author":"Jabben","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.schres.2012.12.023_bb0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1750-1326-6-69","article-title":"Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease","volume":"6","author":"Jiang","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2012.12.023_bb0195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.amjcard.2007.11.006","article-title":"Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls","volume":"101","author":"Kop","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.schres.2012.12.023_bb0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-5-8","article-title":"Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease","volume":"5","author":"Koprich","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1590\/S1516-44462011005000009","article-title":"Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance","volume":"33","author":"Kunz","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"8","key":"10.1016\/j.schres.2012.12.023_bb0210","first-page":"939","article-title":"Association between the interleukin-1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment. American journal of medical genetics","volume":"141B","author":"Mata","year":"2006","journal-title":"Part B: Neuropsychiatr. Genet."},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","article-title":"Evidence of a cytokine model for cognitive function","volume":"33","author":"McAfoose","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.schres.2012.12.023_bb0220","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0225","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1753425911421512","article-title":"Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells","volume":"18","author":"Nahman","year":"2012","journal-title":"Innate Immun."},{"issue":"6","key":"10.1016\/j.schres.2012.12.023_bb0230","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/PSY.0b013e3181de8678","article-title":"Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin","volume":"72","author":"Norman","year":"2010","journal-title":"Psychosom. Med."},{"issue":"6","key":"10.1016\/j.schres.2012.12.023_bb0235","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbi.2009.04.003","article-title":"Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue","volume":"23","author":"Orre","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2012.12.023_bb0240","article-title":"Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial","author":"Prasad","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2012.12.023_bb0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biopsych.2008.09.027","article-title":"Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia","volume":"65","author":"Prata","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2012.12.023_bb0250","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.gene.6364393","article-title":"Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels","volume":"8","author":"Rafiq","year":"2007","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0447.2007.01135.x","article-title":"Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study","volume":"117","author":"Ringen","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"26","key":"10.1016\/j.schres.2012.12.023_bb0260","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.lfs.2005.12.016","article-title":"No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress","volume":"78","author":"Rohleder","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.schres.2012.12.023_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-244X-7-66","article-title":"Item response analysis of the Positive and Negative Syndrome Scale","volume":"7","author":"Santor","year":"2007","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/nedt.1.2.171.61048","article-title":"Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication","volume":"1","author":"Schmitt","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psychres.2004.04.012","article-title":"Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients","volume":"134","author":"Sirota","year":"2005","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2012.12.023_bb0280","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.10r06823","article-title":"Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis","volume":"73","author":"Sommer","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2012.12.023_bb0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2009.01.010","article-title":"Impaired long term memory consolidation in transgenic mice overexpressing the human soluble form of IL-1ra in the brain","volume":"208","author":"Spulber","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0290","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0896-6273(93)90312-F","article-title":"Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus","volume":"10","author":"Tchelingerian","year":"1993","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.schres.2012.12.023_bb0295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cyto.2010.04.013","article-title":"Genetic determinants of circulating levels of tumor necrosis factor receptor II and their association with TNF-RII gene polymorphisms","volume":"51","author":"Vistoropsky","year":"2010","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0305","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/hmg\/ddq471","article-title":"Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries","volume":"20","author":"Williams","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"1\u20133","key":"10.1016\/j.schres.2012.12.023_bb0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.schres.2010.05.007","article-title":"Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls","volume":"122","author":"Wirgenes","year":"2010","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2012.12.023_bb0315","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","article-title":"Immune modulation of learning, memory, neural plasticity and neurogenesis","volume":"25","author":"Yirmiya","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.schres.2012.12.023_bb0320","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00213-008-1295-4","article-title":"Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics","volume":"201","author":"Zhang","year":"2008","journal-title":"Psychopharmacology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T21:57:27Z","timestamp":1539899847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996413000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":63,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0920996413000108"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2012.12.023","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}